Carlos Alban, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 14,867 shares at $48.01 ($712K) on 2011-02-28, disclosed to the SEC on 2011-03-02.
Scheduled sale ($712k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.64 | 5,374 | $256K | 36.0% |
| 2 | $47.99 | 700 | $34K | 4.7% |
| 3 | $47.99 | 5,883 | $282K | 39.7% |
| 4 | $48.00 | 2,100 | $101K | 14.2% |
| 5 | $48.01 | 810 | $39K | 5.5% |
| Total | $47.87 avg | 14,867 |
| $712K |
| 100% |
| Filing → |
| ABBV | SELL | 2018-03-02 | $19.1M | — | Filing → |
| ABBV | SELL | 2017-06-15 | $3.2M | — | Filing → |
| ABBV | SELL | 2017-05-08 | $2.9M | — | Filing → |